Ovarian cancer is categorized as advanced once the cancer has spread away from its site of origin in the pelvis. OncoQuest is grateful to all the listed investigators in Canada for participating in FLORA-5, which begins enrolling on May 1, 2021. Many clinical trials are currently taking place to look at new ways to prevent, find, and treat ovarian cancer. Talk to your health care team to find out if you‘re a candidate for clinical trials.
| Principle Investigator | Location |
| Dr. Mélanie Arbour-Levert⠀⠀⠀⠀⠀⠀⠀⠀⠀ | Cité de la Santé de Laval Laval, QC |
| Dr. Allan Covens | Toronto Sunnybrook Hospital Toronto, ON |
| Dr. Lucy Gilbert | McGill University Health Centre Glen Site/Royal Victoria Hospital Montreal, QC |
| Dr. Diane Provencher | CHUM Centre de Recherche Montreal, QC |
| Dr. Paul Bessette | CHUS – Hôpital Fleurimont Sherbrooke, QC |
| Dr. Katharina Kieser | Queen Elizabeth II Health Sciences Centre Halifax, NS |
